These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 19998159

  • 1. Enhancing informed consent in clinical trials and exploring resistances to disclosing adverse clinical trial results.
    Banja JD, Dunlop B.
    Am J Bioeth; 2009 Aug; 9(8):39-41. PubMed ID: 19998159
    [No Abstract] [Full Text] [Related]

  • 2. Disclosing clinical trial results: publicity, significance and independence.
    Liao SM, Sheehan M, Clarke S.
    Am J Bioeth; 2009 Aug; 9(8):W3-5. PubMed ID: 19998144
    [No Abstract] [Full Text] [Related]

  • 3. Conflating scientific with clinical considerations.
    van der Graaf R, van Delden JJ.
    Am J Bioeth; 2009 Sep; 9(9):58-9. PubMed ID: 19998198
    [No Abstract] [Full Text] [Related]

  • 4. Improving subject recruitment by maintaining truly informed consent: a practical benefit of disclosing adverse clinical trial results.
    Shah KR, Batzer FR.
    Am J Bioeth; 2009 Aug; 9(8):36-7. PubMed ID: 19998157
    [No Abstract] [Full Text] [Related]

  • 5. A clinical perspective on placebo research: looking back, looking forward.
    Dworkin RW.
    Am J Bioeth; 2009 Sep; 9(9):54-5. PubMed ID: 19998196
    [No Abstract] [Full Text] [Related]

  • 6. The fetus as a patient and the ethics of human subjects research: response to commentaries on "An ethically justified framework for clinical investigation to benefit pregnant and fetal patients".
    McCullough LB, Chervenak FA.
    Am J Bioeth; 2011 May; 11(5):W3-7. PubMed ID: 21534136
    [No Abstract] [Full Text] [Related]

  • 7. What it takes to defend deceptive placebo use.
    Barnhill A.
    Kennedy Inst Ethics J; 2011 Sep; 21(3):219-50. PubMed ID: 22073816
    [Abstract] [Full Text] [Related]

  • 8. Respecting participant autonomy and the disclosure of clinical trial results.
    Oakley J.
    Am J Bioeth; 2009 Aug; 9(8):38. PubMed ID: 19998158
    [No Abstract] [Full Text] [Related]

  • 9. Reviewing the unsubstantiated claims for the methodological superiority of 'placebo' over 'active' controlled trials: reply to open peer commentaries.
    Howick J.
    Am J Bioeth; 2009 Sep; 9(9):W5-7. PubMed ID: 19998178
    [No Abstract] [Full Text] [Related]

  • 10. The duty to disclose (even more) adverse clinical trial results.
    Hassoun N.
    Am J Bioeth; 2009 Aug; 9(8):33-4. PubMed ID: 19998155
    [No Abstract] [Full Text] [Related]

  • 11. Disclosure of adverse clinical trial results--should legal immunity be granted to drug companies?
    Vernillo A.
    Am J Bioeth; 2009 Aug; 9(8):45-7. PubMed ID: 19998162
    [No Abstract] [Full Text] [Related]

  • 12. Response to open peer commentaries on "assessing the remedy: the case for contracts in clinical trials".
    Edwards SJ.
    Am J Bioeth; 2011 Apr; 11(4):W1-3. PubMed ID: 21480062
    [No Abstract] [Full Text] [Related]

  • 13. Disclosing controversial risk in informed consent: how serious is serious?
    Kocarnik JM.
    Am J Bioeth; 2014 Apr; 14(4):13-4. PubMed ID: 24730481
    [No Abstract] [Full Text] [Related]

  • 14. Ethical issues in the difference between placebo-controlled and active-controlled trials.
    Petrini C.
    Am J Bioeth; 2009 Sep; 9(9):56-8. PubMed ID: 19998197
    [No Abstract] [Full Text] [Related]

  • 15. The ethics of disclosing to research subjects the availability of off-label marketed drugs.
    Taylor HA, Kuwana E, Wilfond BS.
    Am J Bioeth; 2014 Sep; 14(4):51. PubMed ID: 24730496
    [No Abstract] [Full Text] [Related]

  • 16. Who's in control of the choice of control?
    Anderson JA.
    Am J Bioeth; 2009 Sep; 9(9):60-2. PubMed ID: 19998199
    [No Abstract] [Full Text] [Related]

  • 17. Research, medicine, and "placebos".
    Moerman DE.
    Am J Bioeth; 2009 Sep; 9(9):64-5. PubMed ID: 19998201
    [No Abstract] [Full Text] [Related]

  • 18. Challenging the requirements for disclosing risk to clinical research participants.
    Markman M.
    Am J Bioeth; 2014 Sep; 14(4):11-2. PubMed ID: 24730480
    [No Abstract] [Full Text] [Related]

  • 19. An ethically justified framework for clinical investigation to benefit pregnant and fetal patients.
    Chervenak FA, McCullough LB.
    Am J Bioeth; 2011 May; 11(5):39-49. PubMed ID: 21534151
    [Abstract] [Full Text] [Related]

  • 20. Precautionary harm disclosure in clinical trials.
    Wu KC.
    Am J Bioeth; 2009 Aug; 9(8):43-5. PubMed ID: 19998161
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.